Literature DB >> 19617781

Management of progressive myopathic blepharoptosis with daily application of octyl-2-cyanoacrylate liquid bandage.

Tammy H Osaki1, Midori H Osaki, Rubens Belfort, Teissy Osaki, Ana Estela Sant'anna, Daniel K Haraguchi.   

Abstract

PURPOSE: To describe the results of a conservative and reversible technique for the treatment of progressive myopathic blepharoptosis in cases when surgery is not indicated, using octyl-2-cyanoacrylate liquid bandage.
METHODS: Ten consecutive patients with progressive myopathic blepharoptosis were studied. Octyl-2-cyanoacrylate liquid bandage was applied to the upper eyelid to create a deeper eyelid crease. Margin reflex distance, photographs, and visual fields were obtained prior to and after treatment.
RESULTS: All patients described a better appearance after application of the product, and none had an allergic response. All cases had an increase in the margin reflex distance and improvement in visual fields.
CONCLUSION: Octyl-2-cyanoacrylate liquid bandage is an alternative method that is simple, safe, and effective in the management of severe blepharoptosis. Moreover, it can be used in patients without systemic conditions or those who are unwilling to undergo a surgical procedure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617781     DOI: 10.1097/IOP.0b013e3181ac4fd3

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

1.  Tarsal switch using an anterior approach to correct severe ptosis.

Authors:  Roberta Lilian Fernandes de Sousa Meneghim; Lucieni Barbarini Ferraz; Alicia Galindo-Ferreiro; Rajiv Khandekar; Hortensia Sanchez-Tocino; Silvana Schellini
Journal:  Arch Plast Surg       Date:  2018-03-15

2.  Therapeutic effects of a liquid bandage prepared with cellulose powders from Styela clava tunics and Broussonetia kazinoki bark: Healing of surgical wounds on the skin of Sprague Dawley rats.

Authors:  Jin Ju Park; Ji Eun Kim; Woo Bin Yun; Mi Rim Lee; Jun Young Choi; Bo Ram Song; Hong Joo Son; Yong Lim; Hyun-Gu Kang; Beum Soo An; Seung Yun Yang; Sung Baek Seo; Dae Youn Hwang
Journal:  Mol Med Rep       Date:  2018-11-19       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.